It is also eyeing £2 billion plus in sales for HIV pre-exposure prophylaxis (PrEP) drug Cabenuva (cabotegravir), hepatitis B virus (HBV) antisense drug GSK3228836, and Zejula (niraparib), the ...
Regeneron released a strong financial report for Q3 and was the 15th of 16 in the last four years. Read why I upgrade REGN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback